These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33418856)

  • 21. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes zoster in an adult recipient of live attenuated varicella vaccine.
    Hammerschlag MR; Gershon AA; Steinberg SP; Clarke L; Gelb LD
    J Infect Dis; 1989 Sep; 160(3):535-7. PubMed ID: 2547882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The current status of live attenuated varicella vaccine.
    Gershon AA
    Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella vaccination after fingolimod: A case report.
    Berger JR
    Mult Scler Relat Disord; 2013 Oct; 2(4):391-4. PubMed ID: 25877852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data.
    Woodward M; Marko A; Galea S; Eagel B; Straus W
    Open Forum Infect Dis; 2019 Aug; 6(8):. PubMed ID: 31392326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.
    van der Heiden M; de Rond LGH; van Zelm MC; Berbers GAM; Boots AMH; Buisman AM
    Front Immunol; 2018; 9():46. PubMed ID: 29410671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination.
    Naseri A; Good WV; Cunningham ET
    Am J Ophthalmol; 2003 Mar; 135(3):415-7. PubMed ID: 12614776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes zoster after vaccination with one dose varicella vaccine to a 4-year-old child.
    Pelekouda E; Papagiannis D; Tsiaousi I; Maltezou HC
    Infez Med; 2019 Dec; 27(4):449-451. PubMed ID: 31846998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
    Uebe B; Sauerbrei A; Burdach S; Horneff G
    Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
    Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.
    Issa NC; Marty FM; Leblebjian H; Galar A; Shea MM; Antin JH; Soiffer RJ; Baden LR
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):285-7. PubMed ID: 24269706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact.
    Shiraki K; Horiuchi K; Asano Y; Yamanishi K; Takahashi M
    J Med Virol; 1991 Feb; 33(2):128-32. PubMed ID: 1675658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
    Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
    Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
    Gabutti G; Franchi M; Maniscalco L; Stefanati A
    Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.